Goshorn et al. Common structural features among monoclonal antibodies binding the same antigenic region of cytochrome c, J. Biol. Chem. 266:2134-2142, 1991.* |
Kettleborough et al. Humanization of a mouse monoclonal antibody by CDR-grafting: the importance of framework residues on loop conformation, Protein Engineering 4:773-783, 1991.* |
Kishima et al “Humanization of Mouse Monoclonal Antibody ONS-M21, Directed Against Human Medulloblastoma and Gliomas”, 1994 Narito Kinin Conference.* |
S. Moriuch et al., “Characterisation of a new mouse monoclonal antibody (ONS-M21) reactive with both Medullo blastomas and glimoas”, (Nov. 1993), British Journal of Cancer, vol. 68, No. 5, p. 831-837. |
J.S. Huston et al., “Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin Single-chain Fv analogue produced in . . .”, (Aug. 1988), Proc. Nat. Acad, Sci. USA, vol. 85, p. 5879-5883. |
“The 6th Annual Meeting, Society for Brain and Immunology Investigation of V region gene sequence of anti-medulloblastoma monoclonal antibody (ONS-M21)”., Moriuchi et al, Jul. 3, 1993. |
“Molecular Approaches to Cancer Immunotherapy”., American Association for Cancer Research—Special Conference—Nov. 9, 1993. Ralph A. Reisfeld, chairperson. |
The 16th Annual Meeting, The Molecular Biology Society of Japan-“Production of Humanized Mouse Monoclonal Antibody ONS-M21”., Ohtomo et al, Dec. 16, 1993. |
The Annual Meeting, The Japan Neurosurgical Society-“Production of Humanized Anti-Medulloblastoma and Glioma Monoclonal Antibody (ONS-M21)”., Moriuchi et al., Dept. of Neurosurgery, Osaka Medical School, Apr. 1994. |
The 39th Kinki Noshoyo Kenkyukai— “Humanization of Anti-Medulloblastoma Monoclonal Antibody (ONS-M21)” Moriuchi et al., Dept. of Neurosurgery, Osaka Medical School/Fuji-Gotemba Institute of Chugai Pharmaceutical Co., Ltd.; Apr. 16, 1994. |
The 7th Annual Meeting, Society for Brain and Immunology-“Humanization of Mouse Monoclonal Antibody ONS-M21 Directed Against Human Medulloblastoma and Glioma”., Ohtomo et al., Chugai Pharmaceutical Co., Osaka Univ. Med., Neurosurgery, Jul. 2, 1994. |
The Annual Meeting, The Japan Neurological Society-Humanization of Mouse Monoclonal Antibody ONS-M21 Directed Against Human Medulloblastoma and Glioma., Moriuchi et al., Dept. of Neurosurgery Osaka University Medical School/Fuji-Gotemba Institute of Chugai Pharmaceutical Co., Ltd. 1994. |
The 17th Annual Meeting, The Molecular Biology Society of Japan-“Construction of Single-Strand Fv Region of Humanized Anti-Medulloblastoma Antibody ONS-M21”., Ohtomo et al., Fuji-Gotemba Institute of Chugai Pharmaceutical Co., Ltd., Osaka University Medical School, Dept. of Neurosurgery, Dec. 1994. |
The 8th Annual Meeting, Society for Brain and Immunology Humanization of Mouse Monoclonal Anti-body ONS-M21., Ohtomo et al., Fuji-Motemba Institute of Chugai Pharmaceutical Co., Ltd. Aug. 1995. |
“Humanization of Mouse ONS-M21 Antibody with the Aid of Hybrid Variable Regions”, Molecular Immunology, vol. 32, No. 6, pp. 407-416., Jun. 28, 1994. |
P. Carter et al., “Humanization of an Anti-p185HER2 Antibody for Human Cancer Therapy”, Proc. Natl. Acad. Sci. USA, vol. 89, No. 10, May 1992, pp. 4285-4289. |
K. Sato et al., “Reshaping a Human Antibody Inhibit the Interleukin 6-dependent Tumor Cell Growth”, Cancer Research, vol. 53, Feb. 1993, pp. 851-856. |
D. Colcher et al., “In Vivo Tumor Targeting of a Recombinant Single-Chain Antigen-Binding Protein”, Journal of the National Cancer Institute, vol. 82, No. 14, Jul. 1990. |
T. Ohtomo et al., “Humanization of Mouse ONS-M21 Antibody with the Aid of Hybrid Variable Regions”, Molecular Immunology, vol. 32, No. 6, 1995, pp. 407-416. |